Hyftor Approved for Facial Angiofibroma Associated With Tube

The FDA has approved Hyftor (sirolimus topical gel) for facial angiofibroma associated with tuberous sclerosis complex in patients aged ≥6 years.

Related Keywords

, Drug Administration , Markedly Improved ,